high level of glutathione-6-dehydrogenase level Frontiers Metabolism: The pentose phosphate pathway
Description
Giblett, A
Thus, these data indicate that Fasn and Scd1 may act within the same lipogenic pathway downstream of GSH depletion and that inhibition of either enzyme is sufficient to occlude the lipid-lowering effect
This estimate is based on the growing prevalence of metabolic risk factors such as obesity, type 2 diabetes, and dyslipidemia
What is a Glutathione Injection
